Navigation Links
UPDATE: Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
Date:7/22/2009

Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference

Access to Provide Details on MuGard Launch in Europe

ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that Jeffrey B. Davis, President & CEO, will present at the Jesup & Lamont 2009 Growth Stock Conference organized by the LifeTech Capital Group on Thursday, July 30, 2009 at 10:45 am EDT. The presentation will occur live and will be held at the Waldorf Astoria Boca Beach Club in Boca Raton, Florida.

"We are pleased to have the opportunity to present Access Pharmaceuticals to the large group of institutional and retail investors that attend Jesup's annual growth stock conference," stated Jeffrey B. Davis, Access' President & CEO. "The conference provides a forum for Access to highlight in many product programs, and specifically the very significant and positive initial results and feedback from the commercial launch of MuGard, our FDA approved treatment for oral mucositis. Initial clinical feedback and experience exceeds our expectations."

About Access: Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase 2 clinical testing of patients with ovarian cancer, and MuGard(TM) for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin(TM)-mediated targeted delivery and oral drug delivery, its pr
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. PA Game Commission: EHD Outbreak Update: Test Results Confirm EHD In Beaver County
2. UPDATE: Governor Rendell to Fight to Cover All Pennsylvanians During Statewide Bus Tour
3. Update: SpineMark Expands Management Team to Build Spine Care Network
4. Skin Cancer Prevention Update:
5. Update: Oscar-Nominated Actress Signs on as Neutrogena(R) Brand Ambassador
6. VoIP-PAL.com, Inc. (Pink Sheets: VPLM.PK - News) UPDATE: Announces First Award Recipient of TalkfortheCure(TM) Dollars
7. UPDATE: Retirement Living TV Partners With Maryland Public Television to Address the Issue of Healthcare in America Through Its Series Healthcare 08: Search for Solutions
8. UPDATE: Celebrating UC Success Announces Essay Contest Winners
9. UPDATE: Defense Health Board Traumatic Brain Injury Family Caregivers Panel
10. TCT update: press conference schedule announced for TCT
11. Economic Update: You Should Invest (in Your Appearance)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... LOS ANGELES, Dec. 17 ... and Energy-X lip balms, today announced the launch ... natural therapeutic heating/cooling treatment packs are specifically designed ... been developed in a variety of applications. Researchers ... allows a specialized corn to hold temperatures for ...
(Date:12/17/2009)... 30-Year Lease Agreement Will Help Stevens Hospital Expand, ... ,, EDMONDS, Wash., Dec. 17 The ... of Snohomish County today approved non-binding terms for ... Hospital to be effective this summer, pending regulatory ... to a hearing in mid-January to learn more ...
(Date:12/17/2009)... stores, gas stations -- and adding to obesity epidemic, study ... hungry while shopping for a new sofa, don,t despair: 22 ... snacks, a new report finds. , In fact, the sale ... to hit most segments of the retail market, say the ... American Journal of Public Health . The easy ...
(Date:12/17/2009)... be more likely to try alcohol, illegal drugs , , ... that smoking cigarettes is riskier than using illicit drugs ... That perception may increase the likelihood that they,ll experiment ... , "We are on the right track with cigarette ... about the dangers of other substances," Pamela S. Hyde, ...
(Date:12/17/2009)... available in Rockville and Gaithersburg, Maryland. This protocol is especially ... asleep during their treatment. , ... (PRWEB) December 17, ... rejoice as The Spinal Correction & Wellness Center has a machine ... are constantly under pressure from gravitational forces which squash the delicately ...
Breaking Medicine News(10 mins):Health News:Thermal-Aid Bears Provide Warm Comfort to Children at Penny Lane for the Holidays 2Health News:Stevens Hospital to Affiliate with Swedish 2Health News:Stevens Hospital to Affiliate with Swedish 3Health News:Stevens Hospital to Affiliate with Swedish 4Health News:Wide Array of Stores Now Sell High-Calorie Snacks 2Health News:Teens Think Smoking More Dangerous Than Drinking, Drugs 2Health News:Rockville and Gaithersburg Now Has Spinal Decompression Therapy 2Health News:Rockville and Gaithersburg Now Has Spinal Decompression Therapy 3
... Life Medals has created sterling silver and 14k gold pendants ... reframe the ... estimated 7 million women,struggle with infertility. Life Medals, LLC has ... "Infertility,Survivors." The fine sterling silver and solid 14k gold pendants ...
... Derma Sciences, Inc.,(OTC Bulletin Board: DSCI), a company specializing ... the upcoming Rodman & Renshaw Annual,Global Investment Conference taking ... City. The Company is scheduled to present on November ... the 4th floor., Management will discuss the Company,s ...
... to investigate new muscle,training methods, WASHINGTON, Oct. ... and fitness research and partnerships, the American College,of ... and health,exchange to highlight scientific discovery and collaboration ... Plaza of,Japan is the first major partnership in ...
... romantic love, study finds , , WEDNESDAY, Oct. 29 (HealthDay ... circuit" in the brain. , This hate circuit shares ... distinct from areas related to emotions such as fear, ... John Romaya, of University College London,s laboratory of neurobiology. ...
... Himes and,Rep. Chris Shays, candidates for US House of ... support a comprehensive,strategy to fight HIV/AIDS in the US ... are HIV-positive, and in 2006 there,were 422 new cases, ... for Disease Control. Approximately 56,000 people are infected with,HIV ...
... within statutory 45-day window -, PITTSBURGH, Oct. 29 ... Matrix Laboratories Limited, its India-based,subsidiary in which it holds ... its Vfend(R) Tablets, 50 mg and 200 mg, with ... did not file,a lawsuit against Matrix within the 45-day ...
Other Medicine News:Health News:Infertility Survivor Creates Symbolic Pendant to Honor the Journey. 2Health News:Derma Sciences to Present at The Rodman & Renshaw 10th Annual Healthcare Conference 2Health News:New Program Internationalizes Health and Fitness Research 2Health News:Scientists Identify Brain's 'Hate Circuit' 2Health News:House Candidates Jim Himes and Chris Shays Pledge Action on HIV/AIDS Epidemic 2Health News:Mylan's Matrix First-to-File on Generic Version of Vfend(R) Antifungal 2
(Date:12/17/2009)... Calif., Dec. 17 Beckman Coulter, ... leading developer, manufacturer and marketer of products ... testing, today affirmed its 2009 outlook and ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) ,, Scott ... said, "Despite broad uncertainties throughout the world ...
(Date:12/17/2009)... Dec. 17 The Dr. Paul Janssen ... call for nominations. The $100,000 Award recognizes individuals ... the improvement of human health. Nomination forms ... be accepted until February 15, 2010. The Award ... of the world,s top scientists, which features three ...
(Date:12/17/2009)... Tell Congress to Fix the Bill ,, ... 17th, the Coalition for a Competitive Pharmaceutical Market ... campaign inside-the-Beltway and in select states charging that, ... "greatest holiday gift of all to brand pharmaceutical ... The ads urge the President to tell ...
Breaking Medicine Technology:Beckman Coulter Affirms 2009 Outlook 2Beckman Coulter Affirms 2009 Outlook 3Beckman Coulter Affirms 2009 Outlook 4Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 2Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 3Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 4Coalition for a Competitive Pharmaceutical Market Runs Ads Stating Congress Is Giving 'Greatest Holiday Gift of All to Brand Pharmaceutical Companies' 2Coalition for a Competitive Pharmaceutical Market Runs Ads Stating Congress Is Giving 'Greatest Holiday Gift of All to Brand Pharmaceutical Companies' 3Wounded Warrior Project to Participate in BGC Partners Annual Charity Day 56052 1Wounded Warrior Project to Participate in BGC Partners Annual Charity Day 56052 2Former AVMA President to Head National Health Commission 56050 1Former AVMA President to Head National Health Commission 56050 2ACD Completes the Second Closing of Series A Financing and Initiates Services for Biomarker Validation and Companion Diagnostic Development 13804 1ACD Completes the Second Closing of Series A Financing and Initiates Services for Biomarker Validation and Companion Diagnostic Development 13804 2
... to focus on acute, post-surgical pain, with a follow-on,safety ... Nov. 26 QRxPharma (ASX:,QRX) announced today that a ... several clinical studies to be conducted as part of ... Q8003IR, an immediate,release dual-opioid pain therapy., The initial ...
... III trials of VELCADE in front-line, multiple myeloma to ... Society ... Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM ) today announced that new ... to be,featured at the 49th ASH Annual Meeting in Atlanta, Georgia, ...
Other Medicine Technology:QRxPharma Doses First Patients in Phase III Clinical Trial Program for its 'Dual Opioid' Pain Therapy 2QRxPharma Doses First Patients in Phase III Clinical Trial Program for its 'Dual Opioid' Pain Therapy 3New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma 2New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma 3New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma 4New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma 5New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma 6
... Single-use spray features a ... pumping during shipment. No-touch application ... and burns. Fine, even mist ... and broad areas with less ...
... Prep Gel is a viscous antimicrobial. ... film forming, which creates a desirable ... known to kill pathogens such as ... resistant), fungi, viruses, protozoa, and yeast's. ...
... Solution is the ... povidone-iodine. It is a ... kills gram-positive and gram-negative ... organisms), as well as ...
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
Medicine Products: